Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/10/20 → 8/10/23 |
Funding
- PSI Pharma Support America Inc. ((OE) Prot #CO-338-100 // (OE) Prot #CO-338-100)
- Clovis Oncology, Inc. ((OE) Prot #CO-338-100 // (OE) Prot #CO-338-100)
Prot #CO-338-100: LODESTAR: A Phase 2 MuLticenter, Open-label Study of Rucaparib as Treatment for SoliD Tumors Associated with DEleteriouS MuTations in Homologous RecombinAtion Repair Genes
- Kalyan, Aparna (PD/PI)
Project: Research project